Infosys, TCS and other IT stocks slide for third straight session as AI worries mountIndian IT stocks extended their decline for a fourth straight session as investors trimmed exposure amid weak growth visibility, muted clie...
14 May, 2026, 04.08 PM IST
AI disrupting traditional IT, but will not shrink market: Coforge CEOCoforge sees artificial intelligence as a growth driver, not a threat to the IT services sector. The company reported strong financial resu...
07 May, 2026, 05.46 PM IST
HCL Tech shares give Rs 59,000 crore shock in 3 days as stock down 15%. More pain ahead?HCL Tech shares have plunged sharply after weak Q4 earnings and subdued FY27 guidance, triggering multiple broker downgrades and target cut...
24 Apr, 2026, 10.45 AM IST
HCLTech CEO expects advanced AI services to soften revenue impactThe third largest service provider outperformed its peers, Tata Consultancy Services and Wipro on the count of revenue and profit in its fo...
23 Apr, 2026, 11.07 AM IST
Tech Mahindra shares fall nearly 2% after Q4. Goldman Sachs, Motilal Oswal, other brokerages weigh inTech Mahindra shares slipped after reporting a 16% rise in quarterly profit, with revenue growth supporting sentiment despite cautious outl...
23 Apr, 2026, 09.39 AM IST
IT stocks could return 20-30% from here, but don't expect a structural bull run: Sandip AgarwalIndian IT sector outlook is positive. Fund manager Sandip Agarwal believes the worst is over. A 20-30% index return is possible soon. Clien...
23 Apr, 2026, 09.00 AM IST
HCL Tech's margins and constant currency growth to remain under pressure: Aditya ShahMarket watchers responded cautiously to the latest quarterly numbers, which fell short of expectations in growth and margins. While new dea...
22 Apr, 2026, 05.46 PM IST
Rs 92,000 crore ripple effect! HCL Tech’s weak Q4 drags IT pack; Infosys, Tech Mahindra slump up to 6%HCL Technologies’s weak Q4 triggered a ₹92,000 crore sell-off in IT stocks, dragging peers like Infosys and Tech Mahindra down up to 6% ami...
22 Apr, 2026, 05.45 PM IST
HCL Tech shares wipe out Rs 38,000 crore as target price falls to Rs 1,165. Why every second broker is busy downgradingHCL Technologies share price plummeted nearly 10%, wiping out Rs 38,000 crore in market cap following a brutal Q4 earnings report. The IT m...
22 Apr, 2026, 05.44 PM IST
Infosys Q4 Preview: Can strong earnings offset concerns around AI?Infosys anticipates a subdued March quarter, with revenue growth slowing due to seasonal factors, though full-year targets remain achievabl...
22 Apr, 2026, 01.51 PM IST
Muted Q4, weak forecast cast a shadow on HCLTechHCLTech's revenue growth guidance for FY27 is significantly lower than the actual FY26 growth, implying the effect of growing dependence of...
22 Apr, 2026, 06.02 AM IST
HCL Tech Q4 Results: Cons PAT up 4% YoY at Rs 4,488 crore, revenue rises 12%; Rs 24 per share dividend declaredHCL Tech Q4 Results: IT major HCL Technologies on Tuesday reported a 4.2% growth in its consolidated net profit for the March-ended quarter...
21 Apr, 2026, 08.09 PM IST
Persistent Systems Q4 Results: Profit jumps 34% YoY to Rs 529 crore, revenue up 25%Mid-tier IT services company Persistent Systems on Tuesday reported a 33.73 per cent growth in consolidated net profit to Rs 529.26 crore i...
21 Apr, 2026, 05.05 PM IST
Slow revenue conversion to dog IT companies as AI queers the pitchDecline in annual revenue runs at even the biggest in Indian IT, such as Tata Consultancy Services (TCS) and Wipro, despite healthy deal pi...
18 Apr, 2026, 09.04 AM IST
TCS declares Rs 31 per share final dividend, FY26 payout at Rs 39,571 croreTCS Dividend News: Tata Consultancy Services declared a final dividend of Rs 31 per share for the financial year ending March 31, 2026. The...
09 Apr, 2026, 04.36 PM IST
Zydus gets WHO nod for its typhoid vaccineZydus Lifesciences Ltd has received in-principle approval from the WHO for its Typhoid Vi conjugate vaccine, ZyVac TCV. Eligible for UN pro...
23 Oct, 2024, 12.07 PM IST
Bharat Biotech launches conjugate typhoid vaccineBharat Biotech launched the world’s first clinically proven conjugate Typhoid vaccine ‘Typbar-TCV’, which offers long-term protection.
26 Aug, 2013, 07.42 PM IST